Earlier today, the UK government issued its formal response to Sir Bruce Keogh’s recommendations, made as part of an investigation into practices of both surgical and non-surgical cosmetics procedures. While...
Read MoreThe state of the science of injectable products such as soft tissue fillers and neurotoxins is often a bone of contention in the post-PIP, post-Keogh world of cosmetic surgery. Throughout Europe,...
Read MoreAt the British Association of Aesthetic Plastic Surgeons (BAAPS) conference last month, it was announced that a number of cosmetic surgery clinics are still offering cut-price deals and perks — despite recommendations...
Read MoreAs I have been searching for inspiration for this issue’s editorial, there is really only one thing on my mind at the moment. Those of you who have interacted with me...
Read MoreCrisis management it may be, but the EU is working hard in the wake of the PIP scandal to get its house in order as far as cosmetic surgery regulation and standard-setting are concerned. Opinion is divided as to the best course to take, but the consensus now is that the opportunity to establish a regulatory basis must not be missed. Ashley Yeo reports
Read MoreBreast implants have been the focus of much attention recently, mainly for the wrong reasons. But confidence in the market remains high, as 2011 procedure volumes in the UK and US show. The UK’s BAAPS president‑elect, Rajiv Grover, and the US ASPS president, Malcolm Roth, give their views on general business trends to Ashley Yeo
Read More
